These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
62. Protective effect of metformin against tuberculosis infections in diabetic patients: an observational study of south Indian tertiary healthcare facility. Marupuru S; Senapati P; Pathadka S; Miraj SS; Unnikrishnan MK; Manu MK Braz J Infect Dis; 2017; 21(3):312-316. PubMed ID: 28199824 [TBL] [Abstract][Full Text] [Related]
64. New therapeutic targets in the treatment of age-related macular degeneration. Muñoz-Ramón PV; Hernández Martínez P; Muñoz-Negrete FJ Arch Soc Esp Oftalmol (Engl Ed); 2020 Feb; 95(2):75-83. PubMed ID: 31787390 [TBL] [Abstract][Full Text] [Related]
65. A decade of progress in the understanding, prevention and treatment of age-related macular degeneration in Singapore. Wagle AM; Au Eong KG Ann Acad Med Singap; 2015 Apr; 44(4):116-8. PubMed ID: 26041634 [No Abstract] [Full Text] [Related]
66. How much do you know about metformin? Paulsen T Diabetes Self Manag; 2010; 27(4):28, 30. PubMed ID: 20707243 [No Abstract] [Full Text] [Related]
69. Incidence of metformin use in patients with age-related macular degeneration versus normal controls: A population-based study in Olmsted County, Minnesota. Starr MR; Dalvin LA; AbouChehade JE; Damento GM; Garcia M; Shah SM; Hodge DO; Iezzi R; Bakri SJ Eye (Lond); 2023 Jun; 37(9):1861-1865. PubMed ID: 36151313 [TBL] [Abstract][Full Text] [Related]
70. Will delayed release metformin provide better management of diabetes type 2? Scheen AJ Expert Opin Pharmacother; 2016; 17(5):627-30. PubMed ID: 26830975 [No Abstract] [Full Text] [Related]
71. The effect of metformin on lung cancer risk and survival in patients with type 2 diabetes mellitus: A meta-analysis. Xiao K; Liu F; Liu J; Xu J; Wu Q; Li X J Clin Pharm Ther; 2020 Aug; 45(4):783-792. PubMed ID: 32406122 [TBL] [Abstract][Full Text] [Related]
72. [Anti-oncogenic effect of metformin]. Noto H Nihon Rinsho; 2016 Apr; 74 Suppl 2():693-6. PubMed ID: 27266176 [No Abstract] [Full Text] [Related]
73. Use of intravenous contrast agents in patients receiving metformin. Gupta R Radiology; 2002 Oct; 225(1):311-2; author reply 312. PubMed ID: 12355024 [No Abstract] [Full Text] [Related]
74. Metformin for prediabetes. Med Lett Drugs Ther; 2016 Nov; 58(1507):141. PubMed ID: 27805573 [No Abstract] [Full Text] [Related]
76. Potential risks of metformin in transplant patients. Larsen JL Am J Transplant; 2012 Mar; 12(3):795; author reply 796. PubMed ID: 22233137 [No Abstract] [Full Text] [Related]
77. Metformin prevents the onset and progression of intervertebral disc degeneration: New insights and potential mechanisms (Review). Yang W; Yang Y; Wang Y; Gao Z; Zhang J; Gao W; Chen Y; Lu Y; Wang H; Zhou L; Wang Y; Li J; Tao H Int J Mol Med; 2024 Aug; 54(2):. PubMed ID: 38963023 [TBL] [Abstract][Full Text] [Related]
78. Metformin use in renal disease. Khan M; Siddiqui N J Pak Med Assoc; 2017 Aug; 67(8):1301. PubMed ID: 28839328 [No Abstract] [Full Text] [Related]
79. Should metformin be used to improve blood lipid pattern in nondiabetic patients with coronary heart disease? Hoogeveen EK; Stehouwer CD J Intern Med; 1996 Jul; 240(1):46-7. PubMed ID: 8708595 [No Abstract] [Full Text] [Related]
80. A pharmacist's perspective on metformin use and cancer outcomes. Ceacareanu AC J Pharm Pract; 2015 Feb; 28(1):44-5. PubMed ID: 25715081 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]